Business Development
Pharmacosmos has a strong track record for identification of promising pharmaceutical compounds for iron infusion therapy.
Pharmacosmos has a unique in-house expertise in manufacturing process development according to current Good Manufacturing Practice (GPM) of active pharmaceutical ingredients (API).
Pharmacosmos establishes partnerships and strategic alliances with leading pharmaceutical companies whenever this may advance the development of Pharmacosmos' pharmaceutical compounds.
Pharmacosmos may choose to out-license clinical development of potential pharmaceutical compounds.